BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 20484472)

  • 1. Dose-dependent increase in intratesticular testosterone by very low-dose human chorionic gonadotropin in normal men with experimental gonadotropin deficiency.
    Roth MY; Page ST; Lin K; Anawalt BD; Matsumoto AM; Snyder CN; Marck BT; Bremner WJ; Amory JK
    J Clin Endocrinol Metab; 2010 Aug; 95(8):3806-13. PubMed ID: 20484472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-dose human chorionic gonadotropin maintains intratesticular testosterone in normal men with testosterone-induced gonadotropin suppression.
    Coviello AD; Matsumoto AM; Bremner WJ; Herbst KL; Amory JK; Anawalt BD; Sutton PR; Wright WW; Brown TR; Yan X; Zirkin BR; Jarow JP
    J Clin Endocrinol Metab; 2005 May; 90(5):2595-602. PubMed ID: 15713727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum insulin-like factor 3 is highly correlated with intratesticular testosterone in normal men with acute, experimental gonadotropin deficiency stimulated with low-dose human chorionic gonadotropin: a randomized, controlled trial.
    Roth MY; Lin K; Bay K; Amory JK; Anawalt BD; Matsumoto AM; Marck BT; Bremner WJ; Page ST
    Fertil Steril; 2013 Jan; 99(1):132-139. PubMed ID: 23040523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of gonadotropin withdrawal and stimulation with human chorionic gonadotropin on intratesticular androstenedione and DHEA in normal men.
    Roth MY; Page ST; Lin K; Anawalt BD; Matsumoto AM; Marck B; Bremner WJ; Amory JK
    J Clin Endocrinol Metab; 2011 Apr; 96(4):1175-81. PubMed ID: 21289266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential of testosterone buciclate for male contraception: endocrine differences between responders and nonresponders.
    Behre HM; Baus S; Kliesch S; Keck C; Simoni M; Nieschlag E
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2394-403. PubMed ID: 7543113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulation of sperm production by human chorionic gonadotropin after prolonged gonadotropin suppression in normal men.
    Matsumoto AM; Bremner WJ
    J Androl; 1985; 6(3):137-43. PubMed ID: 3922931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum 17-hydroxyprogesterone strongly correlates with intratesticular testosterone in gonadotropin-suppressed normal men receiving various dosages of human chorionic gonadotropin.
    Amory JK; Coviello AD; Page ST; Anawalt BD; Matsumoto AM; Bremner WJ
    Fertil Steril; 2008 Feb; 89(2):380-6. PubMed ID: 17462643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two-year comparison of testicular responses to pulsatile gonadotropin-releasing hormone and exogenous gonadotropins from the inception of therapy in men with isolated hypogonadotropic hypogonadism.
    Liu L; Banks SM; Barnes KM; Sherins RJ
    J Clin Endocrinol Metab; 1988 Dec; 67(6):1140-5. PubMed ID: 3142911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic human chorionic gonadotropin administration in normal men: evidence that follicle-stimulating hormone is necessary for the maintenance of quantitatively normal spermatogenesis in man.
    Matsumoto AM; Karpas AE; Bremner WJ
    J Clin Endocrinol Metab; 1986 Jun; 62(6):1184-92. PubMed ID: 3084535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of testosterone, estradiol, aromatase inhibitor, gonadotropin and prolactin on the response of mouse testes to acute gonadotropin stimulation.
    Dalterio S; Bartke A; Brodie A; Mayfield D
    J Steroid Biochem; 1983 Apr; 18(4):391-6. PubMed ID: 6834825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Semen quality and reproductive hormones before orchiectomy in men with testicular cancer.
    Petersen PM; Skakkebaek NE; Vistisen K; Rørth M; Giwercman A
    J Clin Oncol; 1999 Mar; 17(3):941-7. PubMed ID: 10071288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poorly controlled type I diabetes mellitus in young men selectively suppresses luteinizing hormone secretory burst mass.
    López-Alvarenga JC; Zariñán T; Olivares A; González-Barranco J; Veldhuis JD; Ulloa-Aguirre A
    J Clin Endocrinol Metab; 2002 Dec; 87(12):5507-15. PubMed ID: 12466346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human chorionic gonadotropin stimulation gives evidence of differences in testicular steroidogenesis in Klinefelter syndrome, as assessed by liquid chromatography-tandem mass spectrometry.
    Belli S; Santi D; Leoni E; Dall'Olio E; Fanelli F; Mezzullo M; Pelusi C; Roli L; Tagliavini S; Trenti T; Granata AR; Pagotto U; Pasquali R; Rochira V; Carani C; Simoni M
    Eur J Endocrinol; 2016 Jun; 174(6):801-11. PubMed ID: 27188454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulsatile gonadotropin-releasing hormone therapy is associated with earlier spermatogenesis compared to combined gonadotropin therapy in patients with congenital hypogonadotropic hypogonadism.
    Mao JF; Liu ZX; Nie M; Wang X; Xu HL; Huang BK; Zheng JJ; Min L; Kaiser UB; Wu XY
    Asian J Androl; 2017; 19(6):680-685. PubMed ID: 28051040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relative roles of follicle-stimulating hormone and luteinizing hormone in maintaining spermatogonial maturation and spermiation in normal men.
    Matthiesson KL; McLachlan RI; O'Donnell L; Frydenberg M; Robertson DM; Stanton PG; Meachem SJ
    J Clin Endocrinol Metab; 2006 Oct; 91(10):3962-9. PubMed ID: 16895950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of GnRH agonist and human chorionic gonadotrophin tests for differentiating constitutional delayed puberty from gonadotrophin deficiency in boys.
    Kauschansky A; Dickerman Z; Phillip M; Weintrob N; Strich D
    Clin Endocrinol (Oxf); 2002 May; 56(5):603-7. PubMed ID: 12030910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GnRH antagonist inhibition of gonadotropin and steroid secretion in boars in vivo and steroid production in vitro.
    Zanella EL; Lunstra DD; Wise TH; Kinder JE; Ford JJ
    J Anim Sci; 2000 Jun; 78(6):1591-7. PubMed ID: 10875643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic GnRH and hCG testing: establishment of new diagnostic reference levels.
    Bang AK; Nordkap L; Almstrup K; Priskorn L; Petersen JH; Rajpert-De Meyts E; Andersson AM; Juul A; Jørgensen N
    Eur J Endocrinol; 2017 Apr; 176(4):379-391. PubMed ID: 28077499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testosterone undecanoate supplementation together with human chorionic gonadotropin does not impair spermatogenesis in males with isolated hypogonadotropic hypogonadism: a retrospective study.
    Chen YW; Niu YH; Xu H; Wang DQ; Jiang HY; Pokhrel G; Wang T; Wang SG; Liu JH
    Asian J Androl; 2019; 21(4):413-418. PubMed ID: 30604694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of gonadotropin-releasing hormone receptor blockade on rat testicular gonadotropin and lactogen receptors, steroidogenesis, and responses to human chorionic gonadotropin stimulation.
    Huhtaniemi IT; Catt KJ
    Endocrinology; 1985 Jan; 116(1):281-7. PubMed ID: 2981066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.